Cancer Therapy: CD44v6‐Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells (Adv. Sci. 1/2017)
Source abstract
Abstract
In article 1600202, CD44v6 peptide functionalized nanoparticles are fabricated in a facile and controllable way to selectively bind to tumor cells with highly efficient anticancer and antimetastatic properties by Veronique Orian-Rousseau, Pavel A. Levkin, and co-workers. The modular synthesis and facile preparation makes this system highly potent for developing novel multifunctional nanocarriers for therapeutic and/or diagnostic anticancer applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute of Toxicology and Genetics Karlsruhe Institute of Technology 76344 Karlsruhe Germany
Institute of Organic Chemistry University of Heidelberg 69120 Heidelberg Germany
Institute of Biological Interfaces (IBG‐2) Karlsruhe Institute of Technology 76344 Karlsruhe Germany
Department of Applied Physical Chemistry University of Heidelberg 69120 Heidelberg Germany
References
Reference metadata was not supplied for this record.